Research on endometrial carcinoma, also called endometrial cancer or uterine cancer

From November 2025

MLL3 mutations predict better survival and response to immunotherapy in endometrial cancer (ref: Liu doi.org/10.1016/j.celrep.2025.116548/)
A prognostic model based on ferroptosis-related lncRNAs effectively predicts outcomes in endometrial cancer (ref: Murakami doi.org/10.21037/atm-25-87/)
Cervical diameter significantly affects sentinel lymph node mapping success in endometrial cancer (ref: Ariola doi.org/10.1016/j.ygyno.2025.11.002/)
HPV vaccination significantly reduces cervical cancer incidence (ref: Henschke doi.org/10.1002/14651858.CD015363.pub2/)
Nivolumab and ipilimumab show a 63% response rate in advanced dMMR/MSI-H cancers (ref: Carlino doi.org/10.1001/jamaoncol.2025.4721/)
Neighborhood socioeconomic status impacts endometrial cancer mortality, highlighting disparities (ref: Araujo doi.org/10.1016/j.ygyno.2025.10.018/)
Machine learning gas sensor technology achieves 96.63% accuracy in detecting gynecological cancers (ref: Eriksson doi.org/10.1016/j.ebiom.2025.106027/)
PAX1/JAM3 methylation testing improves diagnostic accuracy for cervical lesions in postmenopausal women (ref: Peng doi.org/10.1002/ijc.70245/)

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec